Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myelitis NOS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00258843
What this trial is testing

Safety of Imovax Polio in Chinese Infants and Children

Who this might be right for
Poliomyelitis
Sanofi Pasteur, a Sanofi Company 40
Large-scale testing (Phase 3)Study completedNCT05431933
What this trial is testing

Study to Evaluate Eupolio(IPV)'s Safety, Long-term Protective Effect and Boosting Effect of One Booster Dose in the Three Primary Vaccination Plus Boosting Schedule, and Protective Effect in the Schedule With Bivalent OPV in Infants

Who this might be right for
PoliomyelitisVaccine Reaction
LG Chem 2,001
Testing effectiveness (Phase 2)Study completedNCT00355121
What this trial is testing

Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®

Who this might be right for
Meningococcal MeningitisTetanusDiphtheria+2 more
Sanofi 882
Not applicableStudy completedNCT01229579
What this trial is testing

Effect of Zinc Supplementation on Response to Oral Polio Vaccine in Infants in Pakistan

Who this might be right for
Poliomyelitis
Aga Khan University 320
Large-scale testing (Phase 3)Study completedNCT03822754
What this trial is testing

A Clinical Trial to Evaluate the Immunogenicity and Safety of sIPV in a '1+2' Sequential Schedule With bOPV in Infants

Who this might be right for
Poliomyelitis
Sinovac Biotech Co., Ltd 240
Post-approval studies (Phase 4)Study completedNCT01323959
What this trial is testing

Immunogenicity and Safety of Booster Dose of BoostrixTM Polio Vaccine in Previously Boosted Adults

Who this might be right for
Acellular PertussisPoliomyelitisDiphtheria+1 more
GlaxoSmithKline 212
Large-scale testing (Phase 3)Study completedNCT02458183
What this trial is testing

Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS

Who this might be right for
DiphtheriaTetanusPertussis+1 more
Boryung Pharmaceutical Co., Ltd 476
Post-approval studies (Phase 4)Study completedNCT01695798
What this trial is testing

IPV in Moderate to Severe Chronic Malnourished 9-12 Month Old Children in Karachi.

Who this might be right for
Immunity to Polio Vaccines in Malnourished InfantsImmunity to Polio Vaccines in Non-malnourished Infants
Aga Khan University 840
Testing effectiveness (Phase 2)Study completedNCT00831311
What this trial is testing

Study of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared With PENTAXIM™ and ENGERIX B® PEDIATRICO in Argentinean Infants

Who this might be right for
DiphtheriaTetanusPertussis+2 more
Sanofi Pasteur, a Sanofi Company 624
Large-scale testing (Phase 3)Study completedNCT00348387
What this trial is testing

Immunogenicity and Safety of Imovax Polio in Chinese Infants Compared to Local OPV

Who this might be right for
PoliomyelitisPolio
Sanofi Pasteur, a Sanofi Company 600
Early research (Phase 1)Study completedNCT04146285
What this trial is testing

A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Bio-Thera Solutions 15
Early research (Phase 1)Study completedNCT01759602
What this trial is testing

C1-esterase Inhibitor (Cinryze) for Acute Treatment of Neuromyelitis Optica Exacerbation

Who this might be right for
Neuromyelitis Optica
Michael Levy 10
Not applicableEnded earlyNCT07247292
What this trial is testing

Epidemiological Study of Treatment Approaches on AQP4-IgG Positive NMOSD in Russia

Who this might be right for
Rare DiseasesNeuromyelitis Optica Spectrum Disorder (NMOSD)
AstraZeneca 3
Testing effectiveness (Phase 2)Study completedNCT00307567
What this trial is testing

Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488

Who this might be right for
Acellular PertussisTetanusHepatitis B+3 more
GlaxoSmithKline 689
Not applicableUnknownNCT06118398
What this trial is testing

Efgartigimod in Acute Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis OpticaEfgartigimod
Feng Jinzhou 24
Not applicableStudy completedNCT00514033
What this trial is testing

A Post-marketing Safety Study of GSK Bio IPV Vaccine (PoliorixTM) in Korean Children

Who this might be right for
Poliomyelitis
GlaxoSmithKline 349
Testing effectiveness (Phase 2)Study completedNCT00604058
What this trial is testing

Immunogenicity and Safety of Fractional Doses of IPV Intradermally vs Full Doses Intramuscularly

Who this might be right for
Poliomyelitis
Sanofi Pasteur, a Sanofi Company 236
Testing effectiveness (Phase 2)Looking for participantsNCT05549258
What this trial is testing

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Amgen 15
Not applicableNot Yet RecruitingNCT07333196
What this trial is testing

Tongji NADs Cohort

Who this might be right for
Multiple SclerosisNMO Spectrum DisorderAutoimmune Encephalitis+6 more
Tongji Hospital 1,550
Large-scale testing (Phase 3)Study completedNCT05163561
What this trial is testing

Evaluation of Safety and Immunogenicity of Inactivated Adjuvanted Polio Vaccine in Comparison With Licensed Inactivated Poliovirus Vaccine

Who this might be right for
Poliomyelitis
Serum Institute of India Pvt. Ltd. 1,072
Next Page